GRP78: A possible relationship of COVID-19 and the mucormycosis; in silico perspective. - Alaa M. Elgohary; Abdo A. Elfiky; Khaled H. Barakat (Comput. Biol. Medicine, 2021)

Structure-based virtual screening suggests inhibitors of 3-Chymotrypsin-Like Protease of SARS-CoV-2 from Vernonia amygdalina and Occinum gratissimum. - Gideon A. Gyebi; Abdo A. Elfiky; Oludare M. Ogunyemi; Ibrahim M. Ibrahim; Adegbenro P. Adegunloye; Joseph O. Adebayo; Charles O. Olaiya; Joshua O. Ocheje; Modupe M. Fabusiwa (Comput. Biol. Medicine, 2021)

Multidimensional in silico strategy for identification of natural polyphenols-based SARS-CoV-2 main protease (Mpro) inhibitors to unveil a hope against COVID-19. - Sevki Adem; Volkan Eyupoglu; Ibrahim M. Ibrahim; Iqra Sarfraz; Azhar Rasul; Muhammad Ali; Abdo A. Elfiky (Comput. Biol. Medicine, 2022)

Investigating the structure-activity relationship of marine polycyclic batzelladine alkaloids as promising inhibitors for SARS-CoV-2 main protease (Mpro). - Alaa M. Elgohary; Abdo A. Elfiky; Florbela Pereira; Tarek Mohamed Abd El-Aziz; Mansour Sobeh; Reem K. Arafa; Amr El-Demerdash (Comput. Biol. Medicine, 2022)

Interference of Chaga mushroom terpenoids with the attachment of SARS-CoV-2; in silico perspective. - Wael M. Elshemey; Abdo A. Elfiky; Ibrahim M. Ibrahim; Alaa M. Elgohary (Comput. Biol. Medicine, 2022)

Computational identification of drug-like marine natural products as potential RNA polymerase inhibitors against Nipah virus. - Jameel M. Abduljalil; Abdo A. Elfiky; El-Sayed T. A. Sayed; Maha M. AlKhazindar (Comput. Biol. Chem., 2023)

Simulation of gold nanoparticle movement through normal and cancer cell membranes. - Abdo A. Elfiky; Ibrahim M. Ibrahim; Ahmed M. Elghareib; Yousef S. Bashandy; Ahmed Samir; Mayar M. Hamdy; Rana T. Kamal; Fatma G. Amin; Yomna Elkaramany; Anan M. Rashad; Youssef S. Abdelaziz; Mohamed M. Fathey (Comput. Biol. Medicine, 2023)